Re perceived discrepancy between PFS and OS time frames in Roth Report and Clinicaltrials.gov re Hervaxx, I received an email response from the same email address I used to contact the Roth Report writer. The response is as follows:
”You are talking about how long it takes each individual patient to progress or die, on average. I am talking about when enough patients experience that so that they can release the data. They are two very different things.”
I can’t say that I fully understand that, but in relation to the Phase 1 results and the “beautiful numbers”, it infers that not enough patients have progressed or died such that data can be released. Leslie did say something similar.
I just don’t understand how Roth can put a time estimate on it.
In any event, I am confident great things will be achieved well before then.
Go Imugene.
PDS
Roth just rated IMU a buy, page-66
-
- There are more pages in this discussion • 64 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
|
|||||
Last
6.8¢ |
Change
0.006(9.68%) |
Mkt cap ! $499.7M |
Open | High | Low | Value | Volume |
7.3¢ | 8.1¢ | 6.7¢ | $14.56M | 194.2M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 605784 | 6.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.8¢ | 159880 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 605784 | 0.067 |
19 | 2180735 | 0.066 |
20 | 2260954 | 0.065 |
9 | 3671083 | 0.064 |
6 | 674800 | 0.063 |
Price($) | Vol. | No. |
---|---|---|
0.068 | 159880 | 2 |
0.069 | 1070351 | 8 |
0.070 | 1000281 | 7 |
0.071 | 2660302 | 12 |
0.072 | 1439858 | 6 |
Last trade - 16.10pm 02/09/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |